Microspheres in cancer therapy

被引:38
作者
Rajput, M. S. [1 ]
Agrawal, P. [2 ]
机构
[1] IPS Acad, Coll Pharm, Indore 452012, India
[2] MGM Med Coll, Indore 452001, Madhya Pradesh, India
关键词
Cancer; microspheres; TheraSpheres; SIR-Spheres; POSITRON-EMISSION-TOMOGRAPHY; ACRYL GELATIN MICROSPHERES; UTERINE ARTERY EMBOLIZATION; POLYVINYL-ALCOHOL; HEPATOCELLULAR-CARCINOMA; LIVER METASTASES; IN-VITRO; TRANSARTERIAL CHEMOEMBOLIZATION; BIODEGRADABLE MICROSPHERES; Y-90; MICROSPHERES;
D O I
10.4103/0019-509X.73547
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer microsphere technology is the latest trend in cancer therapy. It helps the pharmacist to formulate the product with maximum therapeutic value and minimum or negligible range side effects. Cancer is a disease in which the abnormal cells are quite similar to the normal cells, with just minute genetic or functional change. A major disadvantage of anticancer drugs is their lack of selectivity for tumor tissue alone, which causes severe side effects and results in low cure rates. Thus, it is very difficult to target abnormal cells by the conventional method of the drug delivery system. Microsphere technology is probably the only method that can be used for site-specific action, without causing significant side effects on normal cells. This review article describes various microspheres that have been prepared or formulated to exploit microsphere technology for targeted drug therapy in various cancers. We looked at the usefulness of microspheres as a tool for cancer therapy. The current review has been done using PubMed and Medline search with keywords.
引用
收藏
页码:458 / 468
页数:11
相关论文
共 82 条
[51]   90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver:: Response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imaging [J].
Lewandowski, RJ ;
Thurston, KG ;
Goin, JE ;
Wong, CYO ;
Gates, VL ;
Van Buskirk, M ;
Geschwind, JFH ;
Salem, R .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2005, 16 (12) :1641-1651
[52]   Drug-Eluting Particles for Interventional Pharmacology [J].
Liapi, Eleni ;
Lee, Kwang-Hun ;
Georgiades, Christos C. ;
Hong, Kelvin ;
Geschwind, Jean-Francois H. .
TECHNIQUES IN VASCULAR AND INTERVENTIONAL RADIOLOGY, 2007, 10 (04) :261-269
[53]   Use of PET and PET/CT for Radiation Therapy Planning: IAEA expert report 2006-2007 [J].
MacManus, Michael ;
Nestle, Ursula ;
Rosenzweig, Kenneth E. ;
Carrio, Ignasi ;
Messa, Cristina ;
Belohlavek, Otakar ;
Danna, Massimo ;
Inoue, Tomio ;
Deniaud-Alexandre, Elizabeth ;
Schipani, Stefano ;
Watanabe, Naoyuki ;
Dondi, Maurizio ;
Jeremic, Branislav .
RADIOTHERAPY AND ONCOLOGY, 2009, 91 (01) :85-94
[54]  
MASAKASU K, 2003, BIOMATERIALS, V24, P2955
[55]   CT diagnosis of chyluria after partial nephrectomy [J].
Miller, Frank H. ;
Keppke, Ana L. ;
Yaghmai, Vahid ;
Gabriel, Helena ;
Hoff, Frederick ;
Chowdhry, Aqeel ;
Smith, Norm .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2007, 188 (01) :W25-W28
[56]  
Murthy R, 2006, Biomed Imaging Interv J, V2, pe43, DOI 10.2349/biij.2.3.e43
[57]  
NGUYEN UTL, 2008, THESIS U NEW S WALES
[58]   Advances in nuclear oncology: Microspheres for internal Radionuclide therapy of liver tumours [J].
Nijsen, JFW ;
van het Schip, AD ;
Hennink, WE ;
Rook, DW ;
van Rijk, PP ;
de Klerk, JMH .
CURRENT MEDICINAL CHEMISTRY, 2002, 9 (01) :73-82
[59]   Detection of recurrent and metastatic colorectal cancer: Comparison of position emission tomography and computed tomography [J].
Ogunbiyi, OA ;
Flanagan, FL ;
Dehdashti, F ;
Siegel, BA ;
Trask, DD ;
Birnbaum, EH ;
Fleshman, JW ;
Read, TE ;
Philpott, GW ;
Kodner, IJ .
ANNALS OF SURGICAL ONCOLOGY, 1997, 4 (08) :613-620
[60]  
Osuga K, 2001, Nihon Rinsho, V59 Suppl 6, P534